Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled time : 12:15 save search
Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer trial car-t preclinical pre-clinical designation
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
Published: 2021-11-09 (Crawled : 12:15) - globenewswire.com
CMPS | $8.41 -1.41% -1.43% 290K
|
Health Technology
|
| O: -17.57%
H: 3.31%
C: -11.45%
treatment positive therapy results topline depression trial comp360 psilocybin
Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial
Published: 2021-11-08 (Crawled : 12:15) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
lung cancer therapy cancer phase 3 trial nivolumab
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site
Published: 2021-11-08 (Crawled : 12:15) - globenewswire.com
HSDT | $5.16 -0.39% -0.39% 6.6K
|
Health Technology
|
| O: 1.86%
H: 1.59%
C: -9.21%
trial
INOVIO Further Expands INNOVATE Phase 3 Trial for COVID-19 DNA Vaccine Candidate INO-4800 With Regulatory Authorization from India
Published: 2021-11-03 (Crawled : 12:15) - inovio.com
INO 3 d | $10.22 -7.68% -8.32% 400K
|
Health Technology
|
| O: 2.35%
H: 0.81%
C: 0.67%
covid india vaccine phase 3 trial ino-4800
CSW Industrials Reports Fiscal 2022 Second Quarter and First Half Results; Provides Fiscal 2022 Second Half Guidance
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
CSWI | $234.23 0.77% 0.77% 98K
|
Process Industries
|
| O: -2.51%
H: 0.0%
C: -1.6%
results trials trial
Biogen Announces Late Breakers and Additional New Data Presentations at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.21%
H: 3.05%
C: 2.97%
presentation disease alzheimer clinical trials trials trial alzheimer’s alzheimer's disease alzheimer's
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
CMPS | $8.41 -1.41% -1.43% 290K
|
Health Technology
|
| O: 3.74%
H: 1.26%
C: 0.35%
therapy trial comp360 psilocybin
HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer
Published: 2021-10-28 (Crawled : 12:15) - biospace.com/
HCWB | $1.59 0.0% 2.6K
|
|
| O: 60.62%
H: 50.32%
C: 0.85%
fda clearance fda phase 1 cancer phase 1b trial pancreatic hcw9218 pancreas phase 2b clearance
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
ADAG | $2.53 -0.37% 1.8K
|
Manufacturing
| Email alert
Add to watchlist
lung cancer collaboration cancer trial nivolumab
Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency
Published: 2021-10-25 (Crawled : 12:15) - appliedtherapeutics.com
APLT A | $4.74 -1.86% -1.9% 720K
|
Health Technology
|
| O: -11.84%
H: 14.97%
C: 12.25%
trial biomarkers
CSW Industrials Announces Date for Fiscal 2022 Second Quarter Earnings Release Conference Call
Published: 2021-10-20 (Crawled : 12:15) - globenewswire.com
CSWI | $234.23 0.77% 0.77% 98K
|
Process Industries
|
| O: 0.3%
H: 0.2%
C: -0.85%
trials trial conference
Inhibikase Therapeutics Announces Dosing of First Parkinson's Patient in its Phase 1b Clinical Trial of IkT-148009
Published: 2021-10-19 (Crawled : 12:15) - prnewswire.com
IKT | News | $2.13 0.19% 28K
|
Health Technology
|
| O: 4.0%
H: 7.14%
C: 5.49%
phase 1 ikt-148009 parkinson trial phase 1b phase 2b
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmonary Embolism Patients
Published: 2021-10-18 (Crawled : 12:15) - globenewswire.com
NARI S | $38.63 -0.18% -0.18% 770K
|
Health Technology
|
| O: 1.75%
H: 1.62%
C: 0.19%
trial
Survey Finds Industry Taking Action to Address Challenges from Rapid Move to Decentralized Trials Amid COVID-19
Published: 2021-10-14 (Crawled : 12:15) - prnewswire.com
VEEV | News | $199.54 0.17% -0.27% 850K
|
Technology Services
|
| O: 1.41%
H: 2.41%
C: 1.67%
covid trials trial
Elevation Oncology's Seribantumab Included as Part of a Case Series Presentation at the Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific Meeting
Published: 2021-10-14 (Crawled : 12:15) - biospace.com/
ELEV | $4.03 -2.66% -2.73% 320K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.04%
C: -5.13%
presentation test trials trial
Phase 2 Clinical Trial Data of NurOwn® in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Published: 2021-10-14 (Crawled : 12:15) - biospace.com/
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: -3.38%
multiple sclerosis treatment phase 2 europe sclerosis research trial
VistaGen Therapeutics Expands Clinical Development of PH94B with Initiation of Phase 2A Trial in Adjustment Disorder
Published: 2021-10-14 (Crawled : 12:15) - globenewswire.com
VTGN | $4.69 0.43% 0.43% 200K
|
Health Technology
|
| O: 0.8%
H: 1.59%
C: -0.4%
phase 2 trial phase 2b ph94
Industrial Belt Drives Market Records a CAGR of 3.89% Growth of Industrial Machinery in Developing Countries to Drive Market|17000+ Technavio Reports
Published: 2021-10-07 (Crawled : 12:15) - prnewswire.com
TTFNF | News | $71.0099 -3.76% 1.9K
|
Energy Minerals
|
| O: 0.4%
H: 0.0%
C: -3.79%
growth trial
Industrial Burner Market has Potential to Grow by USD 198.35 Mn | 44% Growth to Originate in APAC | Technavio
Published: 2021-10-06 (Crawled : 12:15) - prnewswire.com
HON | News M | $191.15 0.42% 0.41% 2M
|
Producer Manufacturing
|
| O: -0.9%
H: 1.51%
C: 1.45%
potential growth trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.